Señales en vivo de IMCR | Maximiza tus Ganancias con Getagraph.com

COMPRAR 107345 min ago

@ $71.91

Emitido: 14 feb 2024 @ 15:47

Retorno: -18.70%

Señal anterior: feb 14 - 09:30

Señal anterior: Vender

Retorno: -2.49 %

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases...

Stats
Volumen de hoy	403 551
Volumen promedio	512 688
Capitalización de mercado	2.91B
EPS	$0 ( 2024-02-28 )
Próxima fecha de ganancias	( $-0.320 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-41.17
ATR14	$0.0510 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	St Leger Tina Amber	Sell	4 375	Employee Share Option (Right to Buy)
2024-04-01	St Leger Tina Amber	Buy	4 375	Ordinary Shares
2024-04-01	St Leger Tina Amber	Sell	4 375	Ordinary Shares
2024-02-28	Berman David M	Sell	36 509	Employee Share Option (Right to Buy)
2024-02-28	Berman David M	Buy	36 509	Ordinary Shares

INSIDER POWER
-75.94
Last 63 transactions
Buy: 607 651 \| Sell: 4 752 433

Volumen Correlación

Largo: 0.49 (neutral)

Corto: 0.68 (moderate)

Signal:(74.516) Neutral

Immunocore Holdings plc Correlación

10 Correlaciones Más Positivas
AMRB	0.859
LWAC	0.837
MMAC	0.835

10 Correlaciones Más Negativas
SVAC	-0.83
TLGT	-0.821

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Immunocore Holdings plc Correlación - Moneda/Commodity

0.62
( weak )

0.55
( weak )

0.00
( neutral )

0.62
( weak )

-0.46
( neutral )

-0.56
( weak negative )

Immunocore Holdings plc Finanzas

Annual	2023
Ingresos:	$249.43M
Beneficio Bruto:	$248.39M (99.58 %)
EPS:	$-0.00110

FY	2023
Ingresos:	$249.43M
Beneficio Bruto:	$248.39M (99.58 %)
EPS:	$-0.00110

FY	2022
Ingresos:	$143.74M
Beneficio Bruto:	$143.28M (99.68 %)
EPS:	$-0.900

FY	2021
Ingresos:	$26.52M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-3.10

Financial Reports:

No articles found.

Immunocore Holdings plc

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. In addition, the company's programs for infectious diseases include IMC-I109V, which is in a Phase I/II clinical trial in patients with chronic hepatitis B virus; and IMC-M113V that is in pre-clinical development stage for patients with human immunosuppression virus. Further, it develops product candidates to provide precision targeted immunosuppression for the treatment of autoimmune diseases. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.